For example, use of a colony-stimulating factor 1 receptor (CSF1R) inhibitor for targeting pro-tumour, tumour-associated macrophages in mouse models of LLC and melanoma resulted in the enhanced recruitment of polymorphonuclear myeloid-derived suppressor cells (PMN-MDSC). This evidence concerns the gene CSF1R and neoplasm.